Lv4
670 积分 2022-02-04 加入
Efficacy and safety of dotinurad versus febuxostat for the treatment of gout: a randomised, multicentre, double‐blind, phase 3 trial in China
4小时前
已完结
Efficacy and safety of dotinurad versus febuxostat for the treatment of gout: a randomised, multicentre, double‐blind, phase 3 trial in China
4小时前
已完结
The global burden and epidemiological trends of gout, particularly cases attributable to high Body Mass Index (BMI) in adolescents and young adults (aged 15–39 years): a secondary analysis from global burden of disease study 2021
5小时前
已完结
The Status Quo and Influencing Factors of Self-Management Behavior in Patients with Recurrent Gout in China: A Cross-Sectional Study
5小时前
已完结
Global, regional, and national burden of gout in people aged 15-39 years from 1990 to 2021: trends, cross-country inequalities and forecast to 2035
5小时前
已完结
Systematic analysis of gout burden among young adults in China from 1990 to 2021: findings from the global burden of disease study 2021
5小时前
已完结
Effect of urate-lowering therapy on all-cause and CVD-specific mortality in gout and hyperuricemia: a meta-analysis
6小时前
已完结
Cardiovascular Outcomes of Uric Acid Lowering Medications: A Meta-Analysis
6小时前
已完结
Impacts of Febuxostat on Cerebral and Cardiovascular Events in Elderly Patients with Hyperuricemia: Post Hoc Analysis of a Randomized Controlled Trial
6小时前
已完结
Auswirkungen der Gicht auf die Mortalität aus kardiovaskulären Ursachen: eine Metaanalyse
7小时前
已完结
皖公网安备34019202002308
